LEXINGTON, Mass.--(BUSINESS WIRE)--CoNCERT Pharmaceuticals Inc., the first company dedicated to creating novel medicines utilizing the naturally-occurring element deuterium, announced today the promotion of Nancy Stuart to the role of Chief Operating Officer and the appointment of Jeffrey Williams to the newly created position of Chief Business Officer.
